Aexis Medical
0757.583.361 · rovalta.com · 26/09/2026
Aexis Medical
Financial year 2024 · Closed on 30/09/2024
Overview
Identity
Source · BCE/KBOAexis Medical is a Private limited company incorporated in 2020. Its main activity is: Computer programming activities. Its registered office is in Tienen. It employs on average 18,9 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0757.583.361
- Incorporation
- 28/10/2020
- Legal form
- Private limited company
- Registered office
- Kabbeekvest 67A
3300 Tienen · FlandreSee on map - Contributed capital
- 100 000,00 €
- Latest accounts
- 30/09/2024
- Average workforce
- 18,9 ETP
Financials
Source · NBB, 4 filingsTrend over 4 financial years
| 2024 | 2023 | 2022 | 2021 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | 2,8 M € | +12.9% | 2,4 M € | +5.5% | 2,3 M € | +15.2% | 2 M € |
| EBITDA | 936,9 k € | +29.2% | 725,3 k € | -2.7% | 745,4 k € | +24.8% | 597,5 k € |
| Operating result | 680,4 k € | +38.3% | 492 k € | -4.3% | 514,3 k € | +26.9% | 405,4 k € |
| Net result | 485,2 k € | +41.5% | 343 k € | -3.8% | 356,7 k € | +23.8% | 288,2 k € |
| Balance sheet | |||||||
| Equity | 1,5 M € | +45.4% | 1 M € | +45.6% | 693,2 k € | +91.0% | 363 k € |
| Total assets | 3,8 M € | +14.8% | 3,3 M € | +4.8% | 3,1 M € | +2.1% | 3,1 M € |
| Cash | 1,3 M € | +86.7% | 691,3 k € | -49.6% | 1,4 M € | -4.5% | 1,4 M € |
| Debts | 895,3 k € | -12.7% | 1 M € | -19.0% | 1,3 M € | -19.4% | 1,6 M € |
| Other | |||||||
| Workforce | 18,9 ETP | 0.0% | 18,9 ETP | -0.5% | 19,0 ETP | +24.2% | 15,3 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 30/09/20245 active · 4 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/10/2023 | 01/10/2022 | 01/10/2021 | 28/10/2020 |
| Closing of the financial year | 30/09/2024 | 30/09/2023 | 30/09/2022 | 30/09/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/04/2025 | 30/04/2024 | 28/04/2023 | 27/04/2022 |
| General meeting | 26/03/2025 | 27/03/2024 | 29/03/2023 | 30/03/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 4 filingsValuation
Indicative valuation
As an indication, this company is worth
between 10 M€ and 25 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20245 active · 4 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024485,2 k €↑
- 2023Annual accounts 2023343 k €↓
- 2022Annual accounts 2022356,7 k €↑
- 2021Annual accounts 2021288,2 k €
- 28/10/2020IncorporationPrivate limited company